Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Clinical trial NCT01077960 · COMPLETED

Trial details

NCT number: NCT01077960
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Start date: 2005-02-01
Primary completion: 2006-01-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.